by Admin | June 18, 2014 12:37 pm
June 18, 2014—The Health Resources and Services Administration announced this morning that it stands by its interpretation of the 340B orphan drug exclusion that lets critical access hospitals, sole community hospitals, rural referral centers, and free-standing cancer hospitals access 340B pricing on orphan drugs when they “are used for any indication other than treating the rare disease or condition for which the drug received an orphan designation.”
Source URL: https://340binformed.org/2014/06/hrsa-will-stand-by-its-340b-orphan-drug-exclusion-regulation/
Copyright ©2024 340binformed.org unless otherwise noted.